Stay updated on AK104 in NSCLC Phase II Clinical Trial
Sign up to get notified when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.
Latest updates to the AK104 in NSCLC Phase II Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a new revision entry (v3.4.2) and removed prior notices about funding and operating status. These are administrative updates to the page and do not affect trial data or current study status.SummaryDifference0.9%
- Check23 days agoChange DetectedAdded a site-wide funding notice and a new revision tag (v3.4.1); the previous revision (v3.4.0) is shown as a deletion.SummaryDifference0.9%
- Check30 days agoChange DetectedThe update includes UI additions such as a 'Show glossary' option and color-coded highlights for additions and deletions, along with minor footer/text changes and a revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%
- Check44 days agoChange DetectedRevision v3.3.4 was added to the Record History.SummaryDifference0.1%
- Check65 days agoChange DetectedRevision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check94 days agoChange DetectedAn entry for revision v3.3.2 was added to the history. The previously listed revision v3.2.0 was removed.SummaryDifference0.1%
Stay in the know with updates to AK104 in NSCLC Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.